Abstract
Reduced mobility of the mandible known as trismus is a phenomenon frequently seen in head and neck (H&N) cancer patients and patients with temporomandibular disorders [1–3]. Although numerous advancements have occurred in head and neck oncology practice during the past few decades, survival has not improved significantly. Currently, there is a need for clinical trials that focus not only on survival but also on the patient’s experience and health-related quality of life.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Pauli N, Johnson J, Finizia C, Andréll P. The incidence of trismus and long-term impact on health-related quality of life in patients with head and neck cancer. Acta Oncol. 2013;52:1137–45.
Johnson J, van As-Brooks CJ, Fagerberg-Mohlin B, Finizia C. Trismus in head and neck cancer patients in Sweden: incidence and risk factors. Med Sci Monit. 2010;16:CR278–82.
Manfredini D. Current concepts on temporomandibular disorders. London: Quintessence; 2010.
Dijkstra P, Huisman P, Roodenburg J. Criteria for trismus in head and neck oncology. Int J Oral Maxillofac Surg. 2006;35:337–42.
Scott B, Butterworth C, Lowe D, Rogers SN. Factors associated with restricted mouth opening and its relationship to health-related quality of life in patients attending a maxillofacial oncology clinic. Oral Oncol. 2008;44:430–8.
D'Cruz AK, Vaish R, Kapre N, et al. Elective versus therapeutic neck dissection in node-negative oral cancer. N Engl J Med. 2015;373(6):521–9.
Bernier J, Cooper JS. Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence? Oncologist. 2005;10:215–24.
Bensadoun RJ, Riesenbeck D, Lockhart PB, Elting LS, Spijkervet FK, Brennan MT. A systematic review of trismus induced by cancer therapies in head and neck cancer patients. Support Care Cancer. 2010;18:1033–8.
Louise Kent M, Brennan MT, Noll JL, et al. Radiation-induced trismus in head and neck cancer patients. Support Care Cancer. 2008;16:305–9.
Overgaard J, Hansen HS, Specht L, et al. Five compared with six fractions per week of conventional radiotherapy of squamous- cell carcinoma of head and neck: DAHANCA 6 and seven randomised controlled trial. Lancet. 2003;362:933–40.
Teguh DN, Levendag PC, Voet P, et al. Trismus in patients with oropharyngeal cancer: relationship with dose in structures of mastication apparatus. Head Neck. 2008;30:622–30.
Hoffmann TK. Systemic therapy strategies for head-neck carcinomas: current status. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc03.
Agulnik M. New approaches to EGFR inhibition for locally advanced or metastatic squamous cell carcinoma of the head and neck (SCCHN). Med Oncol. 2012;29:2481–91.
Scott B, D'Souza J, Perinparajah N, Lowe D, Rogers SN. Longitudinal evaluation of restricted mouth opening (trismus) in patients following primary surgery for oral and oropharyngeal squamous cell carcinoma. Br J Oral Maxillofac Surg. 2011;49:106–11.
Buchbinder D, Currivan RB, Kaplan AJ, Urken ML. Mobilization regimens for the prevention of jaw hypomobility in the radiated patient: a comparison of three techniques. J Oral Maxillofac Surg. 1993;51:863–7.
Grandi G, Silva ML, Streit C, Wagner JC. A mobilization regimen to prevent mandibular hypomobility in irradiated patients: an analysis and comparison of two techniques. Med Oral Patol Oral Cir Bucal. 2007;12:E105–9.
Cohen EG, Deschler DG, Walsh K, Hayden RE. Early use of a mechanical stretching device to improve mandibular mobility after composite resection: a pilot study. Arch Phys Med Rehabil. 2005;86:1416–9.
Barañano CF, Rosenthal EL, Morgan BA, McColloch NL, Magnuson JS. Dynasplint for the management of trismus after treatment of upper aerodigestive tract cancer: a retrospective study. Ear Nose Throat J. 2011;90(12):584–90.
Kamstra JI, Reintsema H, Roodenburg JL, Dijkstra PU. Dynasplint Trismus system exercises for trismus secondary to head and neck cancer: a prospective explorative study. Support Care Cancer. 2016;24(8):3315–23.
Shulman DH, Shipman B, Willis FB. Treating trismus with dynamic splinting: a cohort, case series. Adv Ther. 2008;25:9–16.
Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the efficacy of a dynamic jaw opening device (Dyna splint trismus system) as part of the multimodal treatment of trismus in patients with head and neck cancer. Arch Phys Med Rehabil. 2010;91:1278–82.
Brown KE. Dynamic opening device for mandibular trismus. J Prosthet Dent. 1968;20:438–42.
Dijkstra PU, Kropmans TJ, Tamminga RY. Modified use of a dynamic bite opener--treatment and prevention of trismus in a child with head and neck cancer: a case report. Cranio. 1992;10:327–9.
Brunello DL, Mandikos MN. The use of a dynamic opening device in the treatment of radiation induced trismus. Aust Prosthodont J. 1995;9:45–8.
Dijkstra P, Sterken M, Pater R, Spijkervet F, Roodenburg J. Exercise therapy for trismus in head and neck cancer. Oral Oncol. 2007;43:389–94.
Kamstra JI, Roodenburg JL, Beurskens CH, Reintsema H, Dijkstra PU. TheraBite exercises to treat trismus secondary to head and neck cancer. Support Care Cancer. 2013;21:951–7.
Chua DT, Lo C, Yuen J, Foo YC. A pilot study of pentoxifylline in the treatment of radiation-induced trismus. Am J Clin Oncol. 2001;24:366–9.
Hartl DM, Cohen M, Julieron M, Marandas P, Janot F, Bourhis J. Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg. 2008;138:459–63.
King GE, Scheetz J, Jacob RF, Martin JW. Electrotherapy and hyperbaric oxygen promising treatments for postradiation complications. J Prosthet Dent. 1989;62:331–4.
Teguh DN, Levendag PC, Noever I, et al. Early hyperbaric oxygen therapy for reducing radiotherapy side effects: early results of a randomized trial in oropharyngeal and nasopharyngeal cancer. Int J Radiat Oncol Biol Phys. 2009;75:711–6.
Bhrany AD, Izzard M, Wood AJ, Futran ND. Coronoidectomy for the treatment of trismus in head and neck cancer patients. Laryngoscope. 2007;117:1952–6.
Kelsey CR, Jackson L, Langdon S, et al. A polymorphism within the promoter of the TGFb1 gene is associated with radiation sensitivity using an objective radiologic endpoint. Int J Radiat Oncol Biol Phys. 2012;82:247–55.
Ghazali N, Shaw RJ, Rogers SN, Risk JM. Genomic determinants of normal tissue toxicity after radiotherapy for head and neck malignancy: a systematic review. Oral Oncol. 2012;48:1090–100.
Brown JS, Blackburn TK, Woolgar JA, et al. A comparison of outcomes for patients with oral squamous cell carcinoma at intermediate risk of recurrence treated by surgery alone or with postoperative radiotherapy. Oral Oncol. 2007;43:764–73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Anand, A., Mathew, A., Balasubramanian, D. (2018). Trismus in Head and Neck Cancer: Causes and Management. In: Thankappan, K., Iyer, S., Menon, J. (eds) Dysphagia Management in Head and Neck Cancers. Springer, Singapore. https://doi.org/10.1007/978-981-10-8282-5_15
Download citation
DOI: https://doi.org/10.1007/978-981-10-8282-5_15
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-8281-8
Online ISBN: 978-981-10-8282-5
eBook Packages: MedicineMedicine (R0)